A detailed history of Jag Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jag Capital Management, LLC holds 1,198 shares of ABBV stock, worth $213,255. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,198
Previous 1,167 2.66%
Holding current value
$213,255
Previous $200,000 18.0%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $5,079 - $6,179
31 Added 2.66%
1,198 $236,000
Q1 2024

May 01, 2024

BUY
$159.82 - $182.1 $186,509 - $212,510
1,167 New
1,167 $212,000
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $20,038 - $23,197
150 Added 1.28%
11,861 $1.77 Million
Q2 2023

Sep 07, 2023

SELL
$132.51 - $164.9 $56,714 - $70,577
-428 Reduced 3.53%
11,711 $1.58 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $113,693 - $141,484
-858 Reduced 6.83%
11,711 $1.58 Million
Q1 2023

Sep 07, 2023

SELL
$144.61 - $166.54 $14,894 - $17,153
-103 Reduced 0.84%
12,139 $1.93 Million
Q1 2023

Sep 01, 2023

SELL
$144.61 - $166.54 $14,894 - $17,153
-103 Reduced 0.84%
12,139 $1.93 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $139,259 - $160,378
-963 Reduced 7.12%
12,569 $2 Million
Q4 2022

Sep 07, 2023

BUY
$138.31 - $165.87 $73,442 - $88,076
531 Added 4.53%
12,242 $1.98 Million
Q4 2022

Sep 01, 2023

BUY
$138.31 - $165.87 $73,442 - $88,076
531 Added 4.53%
12,242 $1.98 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $60,718 - $72,816
439 Added 3.35%
13,532 $2.19 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $39,994 - $45,871
298 Added 2.33%
13,093 $1.76 Million
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $1.76 Million - $2.24 Million
12,795 New
12,795 $1.96 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jag Capital Management, LLC Portfolio

Follow Jag Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jag Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jag Capital Management, LLC with notifications on news.